Shares of Oracle (ORCL) rose about 4% on Wednesday after Oppenheimer upgraded the stock to Outperform from Perform.
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Ooops... Something went wrong while loading this page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results